Other

Payments for Repurchase of Common Stock

Medtronic Payments for Repurchase of Common Stock decreased by 55.1% to $123.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 95.1%, from $2.49B to $123.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025

How to read this metric

Higher spending indicates a commitment to returning capital to shareholders or offsetting dilution from stock-based compensation.

Detailed definition

The cash outflow associated with the company's repurchase of its own common shares from the open market. This is a prima...

Peer comparison

Standard capital return metric for mature public companies.

Metric ID: other_payments_for_repurchase_of_common_stock

Historical Data

16 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q4 '24Q1 '25Q3 '25Q4 '25Q1 '26
Value$575.00M$315.00M$162.00M$661.00M$1.41B$336.00M$42.00M$170.00M$97.00M$152.00M$2.63B$1.63B$2.49B$2.47B$274.00M$123.00M
QoQ Change-45.2%-48.6%+308.0%+112.7%-76.1%-87.5%+304.8%-42.9%+56.7%>999%-38.1%+53.1%-1.0%-88.9%-55.1%
YoY Change+144.5%+6.7%-74.1%-74.3%-93.1%-54.8%>999%>999%>999%-83.2%-95.1%
Range$42.00M$2.63B
CAGR-33.7%
Avg YoY Growth+813.8%
Median YoY Growth-54.8%
Current Streak3 quarters decline

Frequently Asked Questions

What is Medtronic's payments for repurchase of common stock?
Medtronic (MDT) reported payments for repurchase of common stock of $123.00M in Q2 2025.
How has Medtronic's payments for repurchase of common stock changed year-over-year?
Medtronic's payments for repurchase of common stock decreased by 95.1% year-over-year, from $2.49B to $123.00M.
What does payments for repurchase of common stock mean?
Cash spent by the company to buy back its own common stock.